![]() |
市場調查報告書
商品編碼
1843565
2025年全球醫療診斷人工智慧市場報告AI In Medical Diagnostics Global Market Report 2025 |
||||||
近年來,人工智慧在醫療診斷領域的市場規模迅速擴張,從2024年的19.2億美元成長到2025年的26.6億美元,複合年成長率達38.3%。預測期內的成長歸因於健康意識的提高、慢性病盛行率的上升、老齡化人口的擴大、對天然產品需求的增加以及機能性食品和飲料的擴張。
預計未來幾年,人工智慧在醫療診斷領域的市場將呈指數級成長,到2029年市場規模將達到104.2億美元,複合年成長率高達40.7%。預測期內的成長主要歸因於人們對免疫健康的日益關注、對植物來源產品需求的不斷成長、美容和化妝品行業的擴張、營養保健品和功能性補充劑市場的成長,以及全球永續性和倫理規範的推行。預測期內的關鍵趨勢包括:消費者對機能性食品的認知度和需求不斷提高、營養保健品和膳食補充劑應用範圍的擴大、對天然和植物來源來源的關注、提取和加工技術的創新,以及健康生活方式的興起。
人工智慧在醫學診斷中的應用 將人工智慧應用於治療和醫學診斷領域,用於分析X光、MRI、超音波、 電腦斷層掃描和DXA等醫學影像數據,旨在幫助醫生更準確、更快速地檢測和診斷疾病。
人工智慧在醫療診斷領域的主要組成部分是軟體和服務。醫療診斷軟體能夠影像處理,檢測各種指標,例如細胞內異常增殖的分子,這些分子代表疾病。這個過程涉及的技術包括自然語言處理、電腦視覺、機器學習和情境感知計算。這些技術應用於神經病學、腫瘤學、心血管病學、胸肺病學以及婦產科等專科診斷領域。它們透過電腦輔助檢測、電腦輔助診斷、定量分析工具和臨床決策支援系統等方式應用,並被醫院、影像中心、診斷實驗室和其他醫療營業單位廣泛使用。
美國在2025年春季突然提高關稅及其引發的貿易摩擦,對資訊科技產業,特別是硬體製造、資料基礎設施和軟體部署領域,產生了重大影響。進口半導體、電路基板和網路設備的關稅上漲,推高了高科技公司、雲端服務供應商和資料中心的生產和營運成本。在全球範圍內採購筆記型電腦、伺服器和消費電子產品零件的公司,面臨更長的前置作業時間和價格壓力。同時,對專用軟體徵收的關稅以及主要國際市場的報復性措施,擾亂了全球IT供應鏈,並降低了海外對美國製造技術的需求。為了應對這些挑戰,該產業正在加大對國內晶片生產的投資,擴大供應商網路,並利用人工智慧驅動的自動化技術來增強韌性,更有效地控制成本。
本研究報告是商業研究公司(The Business Research Company)最新系列報告的一部分,提供關於人工智慧在醫療診斷領域應用的市場統計數據,包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商業機會,為您提供在人工智慧醫療診斷行業取得成功所需的全部數據。這份人工智慧醫療診斷市場研究報告全面概述了您所需的一切資訊,並對該行業的現狀和未來發展趨勢進行了深入分析。
未來五年40.7%的預測成長率較我們先前對該市場的預測略微下降了0.6%。這一下降主要歸因於美國與其他國家之間的關稅影響。這可能會直接影響美國,因為依賴日本和荷蘭影像感測器的AI診斷工具成本將會增加,從而限制疾病的早期檢測。此外,由於相互關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易造成的負面影響,這種影響也將更加廣泛。
醫療保健領域投資的成長預計將推動人工智慧在醫療診斷市場的未來發展。醫療保健支出是指公共部門和私部門用於醫療保健服務的總收入比例。這項投資透過為醫療保健專業人員創造就業機會、增加其收入、提高地方政府稅收以及創造對相關產品和服務的需求,支持人工智慧技術在醫療保健領域的應用。例如,根據總部位於加拿大的非營利組織加拿大健康資訊研究所2023年11月發布的報告,預計2023年醫療保健總支出將達到3,440億美元,比前一年略微增加2.8%。因此,醫療保健領域投資的成長是推動人工智慧在醫療診斷市場擴張的關鍵因素。
預計未來幾年,遠端保健和遠端醫療的興起將推動人工智慧在醫療診斷領域的市場成長。遠端醫療利用通訊技術遠端提供廣泛的醫療保健服務和訊息,尤其側重於遠距臨床諮詢和醫療服務。遠端醫療透過遠端患者監護、虛擬諮詢和數位影像分析,提高了遠端醫療環境下的診斷效率。它在影像解讀、病理分析和分流中發揮關鍵作用,確保評估的準確性和及時性。此外,預測分析、與穿戴式裝置的整合以及可擴展的數據管理進一步增強了人工智慧的能力,提高了偏遠和醫療資源匱乏地區的醫療服務可近性和患者療效。例如,根據美國數位健康機構Rock Health在2023年2月進行的一項調查,80%的受訪者在2022年至少使用過一次遠端醫療,高於2021年的72%。因此,遠端醫療和遠距諮詢的成長是推動人工智慧在醫療診斷市場擴張的關鍵因素。
人工智慧在醫療診斷領域的市場正經歷以產品創新為特徵的顯著趨勢,領先企業積極推出新的解決方案以鞏固其市場地位。 2023年3月,新加坡軟體公司Qritive推出了“Qai Prostate”,這是一款專注於前列腺癌診斷的人工智慧工具。這款創新產品能夠區分良性和惡性腫瘤,精準定位前列腺癌病灶,並辨識前列腺腺癌。值得一提的是,Qai Prostate工具能夠幫助病理學家篩選、優先處理並集中精力於最有價值的病例,從而提高實驗室的工作效率。
醫療診斷人工智慧市場的主要企業正策略性地開發醫療影像處理套件,以獲得競爭優勢。醫療圖像涵蓋了用於臨床分析和介入的體內可視化技術和流程。 2022年10月,美國科技公司Google(Google LLC)發布了醫療影像套件(Medical Imaging Suite),這是一項旨在提升醫療影像資料可近性、互通性和易用性的行業解決方案。該套件利用人工智慧進行影像診斷,支援更快、更準確的診斷,提高醫護人員的工作效率,並改善病患預後。該套件包含人工智慧輔助標註工具、基於BigQuery和Looker等工具的高級分析功能、利用Vertex AI加速人工智慧管道開發,以及適用於雲端、本地和邊緣環境的靈活部署選項。這個全面且適應性強的解決方案能夠滿足醫療機構不斷變化的需求。
2024年10月,總部位於美國的醫療科技公司GE醫療科技以約5,300萬美元收購了Intelligent 超音波 Group PLC。此次收購將使GE醫療能夠將Intelligent Ultrasound的AI驅動工具整合到其超音波產品中,旨在簡化工作流程,減少重複性工作,並簡化臨床醫生的超音波檢查。 Intelligent Ultrasound Group PLC是一家總部位於英國的診斷公司,專注於用於醫療診斷的AI主導超音波軟體和培訓工具。
在人工智慧醫療診斷市場中營運的主要企業包括:國際商業機器公司 (IBM)、西門子醫療股份公司 (Siemens Healthineers AG)、通用電氣醫療技術公司 (GE HealthCare Technologies Inc.)、Digital Diagnostics Inc.、Heartflow Inc.、Aidoc Medical Ltd.、皇家飛利浦公司 (Konvidlijke Corporation, Nonvidlike 公司、塔本Corporation)、英特爾公司 (Intel Corporation)、賽靈思公司 (Xilinx Inc)、Enlitic Inc.、Aidence BV、Butterfly Network Inc.、Day Zero Diagnostics Inc.、MicroHealth LLC、Arterys Inc.、PathAI Inc.、Zebra Medical. Medical Inc.、Ultromics Limited、MaxQ AI Ltd. 和 Paige.AI Inc.。
2024年,北美是人工智慧醫療診斷市場最大的區域。預計在預測期內,亞太地區將成為全球人工智慧醫療診斷市場報告中成長最快的區域。此人工智慧醫療診斷市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。
這份人工智慧在醫療診斷的市場報告涵蓋以下國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。
醫療診斷人工智慧市場由提供服務的營業單位所獲得的收入構成,這些服務包括磁振造影(MRI)、超音波、電腦斷層掃描 (CT)、機器人流程自動化 (RPA)、機器學習、自然語言處理和基於規則的專家系統。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關商品的價值。醫療診斷人工智慧市場還包括牙科設備、糖尿病護理設備、腎臟/泌尿系統設備、神經科設備以及用於提供醫療診斷人工智慧服務的實體機器人的銷售額。該市場的價值為“出廠價”,即商品製造商或生產商銷售的商品價值,無論銷售對像是其他營業單位(包括下游製造商、批發商、經銷商和零售商)還是直接銷售給最終客戶。該市場中的商品價值還包括商品製造商提供的任何相關服務。
AI in medical diagnostics involves the application of artificial intelligence in the field of treatment and medical diagnostics. It is employed to analyze medical imaging data, including X-rays, MRIs, ultrasounds, CT scans, and DXAs, with the aim of assisting doctors in more precise and rapid disease discovery and diagnosis.
The primary components of AI in medical diagnostics encompass software and services. The software utilized in medical diagnostics can detect various indicators, such as the abnormal proliferation of molecules in cells that may signify a disease, through image processing. Technologies involved in this process include natural language processing, computer vision, machine learning, context-aware computing, and others. These technologies find applications in specialized diagnostic cases, such as brain and neurological, oncology, cardiac and vascular, chest and lung, obstetrics and gynecology, among others. They are applied through computer-aided detection, computer-aided diagnosis, quantitative analysis tools, and clinical decision support systems, and are utilized by hospitals, diagnostic imaging centers, diagnostic laboratories, and other healthcare entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.
The AI in medical diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in medical diagnostics market statistics, including the AI in medical diagnostics industry global market size, regional shares, competitors with an AI in medical diagnostics market share, detailed AI in medical diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in medical diagnostics industry. This AI in medical diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The ai in medical diagnostics market size has grown exponentially in recent years. It will grow from $1.92 billion in 2024 to $2.66 billion in 2025 at a compound annual growth rate (CAGR) of 38.3%. The growth in the historic period can be attributed to health consciousness, rising incidence of chronic diseases, expanding aging population, increased demand for natural products, expansion of functional foods and beverages.
The ai in medical diagnostics market size is expected to see exponential growth in the next few years. It will grow to $10.42 billion in 2029 at a compound annual growth rate (CAGR) of 40.7%. The growth in the forecast period can be attributed to increasing focus on immune health, rising demand for plant-based products, expanding beauty and cosmetics industry, nutraceuticals and functional supplements market growth, global sustainable and ethical practices. Major trends in the forecast period include rising consumer awareness and demand for functional foods, expanding applications in nutraceuticals and dietary supplements, focus on natural and plant-based sources, innovations in extraction and processing technologies, health and wellness as a lifestyle.
The forecast of 40.7% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by increasing expenses for AI-powered diagnostic tools, dependent on imaging sensors from Japan and the Netherlands, limiting early disease detection. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising investment in healthcare is anticipated to drive the growth of the AI market in medical diagnostics in the future. Health expenditure refers to the share of total revenue allocated by both public and private sectors for healthcare services. This investment creates jobs for healthcare professionals, increases earnings for healthcare workers, boosts municipal tax revenues, and generates demand for related goods and services, thereby supporting the application of AI technology in healthcare. For example, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in November 2023 that total health expenditure is expected to reach $344 billion in 2023, marking a modest increase of 2.8% from the previous year. Thus, the growing investment in healthcare is a key factor driving the expansion of AI in the medical diagnostics market.
The rise in telehealth and telemedicine is expected to drive the growth of the AI market in medical diagnostics in the coming years. Telehealth involves using telecommunications technology to deliver a broad range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. AI enhances diagnostic efficiency in telehealth environments through remote patient monitoring, virtual consultations, and digital imaging analysis. It plays a crucial role in image interpretation, pathology analysis, and triage, ensuring accurate and timely assessments. Additionally, predictive analytics, integration with wearable devices, and scalable data management further strengthen AI capabilities, improving accessibility and patient outcomes in remote or underserved areas. For instance, a survey conducted by Rock Health, a U.S.-based digital health organization, in February 2023 revealed that 80% of respondents had used telemedicine at least once in 2022, up from 72% in 2021. Therefore, the growth of telehealth and telemedicine is a significant factor driving the expansion of AI in the medical diagnostics market.
The AI in medical diagnostics market is witnessing a significant trend characterized by product innovations, with major companies actively introducing new solutions to maintain their market positions. In March 2023, Qritive, a Singapore-based software company, launched the 'Qai Prostate,' an AI-powered tool specifically designed for prostate cancer diagnosis. This innovative product is capable of distinguishing between benign and malignant tumors, precisely identifying the locations of prostatic cancer, and identifying prostatic adenocarcinoma. Notably, the Qai Prostate tool enhances laboratory productivity by allowing pathologists to select, prioritize, and focus on cases that are most beneficial to them.
Major companies in the AI in medical diagnostics market are strategically developing medical imaging suites to gain a competitive advantage. Medical imaging involves techniques and processes that create visual representations of the interior of the body for clinical analysis and medical intervention. In October 2022, Google LLC, a US-based technology company, introduced the Medical Imaging Suite, an industry solution aimed at improving accessibility, interoperability, and usability of healthcare imaging data. The suite leverages AI for imaging to support faster and more accurate diagnosis, enhance productivity for healthcare workers, and improve patient care outcomes. It includes AI-assisted annotation tools, advanced analytics through tools such as BigQuery and Looker, accelerated AI pipeline development with Vertex AI, and flexible deployment options for cloud, on-premises, or edge settings. This comprehensive and adaptable solution addresses the evolving needs of healthcare organizations.
In October 2024, GE HealthCare Technologies Inc., a medical technology company based in the U.S., acquired Intelligent Ultrasound Group PLC for around $53 million. This acquisition allows GE HealthCare to incorporate Intelligent Ultrasound's AI-driven tools into its ultrasound offerings, aiming to improve workflow efficiency, minimize repetitive tasks, and simplify ultrasound examinations for clinicians. Intelligent Ultrasound Group PLC, a diagnostics company located in the UK, focuses on AI-driven ultrasound software and training tools for medical diagnostics.
Major companies operating in the AI in medical diagnostics market include International Business Machines Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Digital Diagnostics Inc., Heartflow Inc., Aidoc Medical Ltd., Koninklijke Philips N.V., Nanox Imaging Ltd., Microsoft Corporation, Nvidia Corporation, Intel Corporation, Xilinx Inc., Enlitic Inc., Aidence B.V., Butterfly Network Inc., Day Zero Diagnostics Inc., MicroHealth LLC, Arterys Inc., PathAI Inc., Zebra Medical Vision Inc., Tempus Labs Inc., Caption Health Inc., Proscia Inc., AliveCor Corporation, ResApp Health Limited, Volpara Health Technologies Limited, Koios Medical Inc., Ultromics Limited, MaxQ AI Ltd., Paige.AI Inc.
North America was the largest region in the AI in medical diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global AI in medical diagnostics market report during the forecast period. The regions covered in the ai in medical diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the ai in medical diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The AI in medical diagnostics market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), ultrasound, and computed tomography scans, robotic process automation, machine learning, natural language processing, and rule-based expert systems. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in the medical diagnostics market also includes sales of dental devices, diabetes care devices, nephrology and urology devices, neurology devices, and physical robots which are used in providing AI in medical diagnostics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI In Medical Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ai in medical diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ai in medical diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in medical diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.